Austco HealthcareASX:AHC +11.36%70 Median PS Value is A$0.16 as of Jun. 25, 2026, which is 100% below its 10-year median of 1.30. GuruFocus rates ASX:AHC with a GF Score™ of 70/100 and a GF Value™ of A$0.33 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 337 Medical Devices & Instruments companies, Austco Healthcare ranks worse than 86.94% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Austco Healthcare's Median PS Value or its related term are showing as below:
ASX:AHC'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.76 Med: 1.3 Max: 2.08
Current: 1.53
During the past 13 years, the highest Price to Median PS Value of Austco Healthcare was 2.08. The lowest was 0.76. And the median was 1.30.
ASX:AHC's Price-to-Median-PS-Value is ranked worse than 86.94% of 337
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs ASX:AHC: 1.53
Austco Healthcare (ASX:AHC) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Austco Healthcare's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.245
/
0.16
=
1.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare Median PS Value Related Terms
Austco Healthcare Median PS Value Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHC vs ISRG, BDX, MDLN: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, Austco Healthcare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.6426.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.249.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a Median PS Value of A$0.16 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Austco Healthcare and its competitors. This is 88% below median its historical median of 1.30. Over the past decade, Austco Healthcare's Median PS Value has ranged from 0.76 to 2.08. According to the industry distribution chart, Austco Healthcare ranks #293 out of 337 companies in the Medical Devices & Instruments industry, placing it in the top 86.9%.
Is Austco Healthcare's Median PS Value too high?
Austco Healthcare's current Median PS Value of A$0.16 is 88% below median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 2.08. Based on the distribution chart, Austco Healthcare ranks #293 out of 337 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Austco Healthcare has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's Median PS Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #293 out of 337 companies for Median PS Value. This places Austco Healthcare in the lower half of its industry. The industry median Median PS Value is 0.70. Historically, Austco Healthcare's own Median PS Value has ranged from 0.76 to 2.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current Median PS Value is A$0.16, which is 88% below median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.33, compared to a current price of A$0.25 — trading 25.8% below its estimated fair value. The current Median PS Value is A$0.16, which is 88% below median its 10-year median of 1.30. Austco Healthcare's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current Median PS Value is A$0.16 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.25 is trading 25.8% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:AHC:
Median PS Value: A$0.16 (88% below median its 10-year median of 1.30)
GF Value™: A$0.33 vs. price of A$0.25 (25.8% below fair value)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
70GF Score
Get the complete analysis for ASX:AHC
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
